The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study.

عرض إصدارات أخرى (1)

<h4>Background</h4>Among patients with idiopathic pulmonary fibrosis (IPF), few studies have investigated the clinical impact of anti-fibrotic treatment (AFT) with and without comorbidities. The aim of the study was to determine whether Charlson Comorbidity Index score (CCIS) can predict...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:PLoS ONE
المؤلفون الرئيسيون: Ayako Aoki, Yu Hara, Hiroaki Fujii, Kota Murohashi, Ryo Nagasawa, Yoichi Tagami, Tatsuji Enomoto, Yutaka Matsumoto, Makoto Masuda, Keisuke Watanabe, Nobuyuki Horita, Nobuaki Kobayashi, Makoto Kudo, Takashi Ogura, Takeshi Kaneko
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Public Library of Science (PLoS) 2023-01-01
الوصول للمادة أونلاين:https://doi.org/10.1371/journal.pone.0291489

الانترنت

https://doi.org/10.1371/journal.pone.0291489

مواد مشابهة